| scholarly article | Q13442814 |
| P50 | author | Gennady Yegutkin | Q42856774 |
| Guido Beldi | Q52355500 | ||
| Mark Exley | Q67650208 | ||
| P2093 | author name string | Yan Wu | |
| Arvand Haschemi | |||
| Daniel Candinas | |||
| Simon C Robson | |||
| Keiichi Enjyoji | |||
| Yara Banz | |||
| Lindsay Miller | |||
| Michael Nowak | |||
| P2860 | cites work | Identification and characterization of CD39/vascular ATP diphosphohydrolase | Q24336540 |
| CD39 modulates endothelial cell activation and apoptosis | Q24678870 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Ectonucleotidases of CD39 Family Modulate Vascular Inflammation and Thrombosis in Transplantation | Q28314900 | ||
| P2X7 receptors regulate NKT cells in autoimmune hepatitis | Q28512178 | ||
| High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors | Q28592075 | ||
| Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation | Q28594120 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 | ||
| The detection of micromolar pericellular ATP pool on lymphocyte surface by using lymphoid ecto-adenylate kinase as intrinsic ATP sensor | Q30477709 | ||
| Natural killer cells lack ecto-5'-nucleotidase | Q31110061 | ||
| Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. | Q31812403 | ||
| Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses | Q31838449 | ||
| Extracellular ATP in T-lymphocyte activation: possible role in effector functions | Q33860736 | ||
| Pharmacology of cloned P2X receptors | Q33932194 | ||
| Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice | Q34983932 | ||
| The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role | Q35553460 | ||
| A T cell-dependent experimental liver injury in mice inducible by concanavalin A | Q35603939 | ||
| Importance of Kupffer cells for T-cell-dependent liver injury in mice | Q35829575 | ||
| To be or not to be NKT: natural killer T cells in the liver. | Q35919440 | ||
| A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model | Q36371388 | ||
| Critical contribution of liver natural killer T cells to a murine model of hepatitis | Q36979591 | ||
| Secretion of IL-2 and IFN-gamma, but not IL-4, by antigen-specific T cells requires extracellular ATP. | Q40665495 | ||
| P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death | Q40958387 | ||
| Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3',5'-cyclic adenosine monophosphate accumulation | Q42116403 | ||
| Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis | Q42157047 | ||
| Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes | Q42635754 | ||
| CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness | Q43943686 | ||
| Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. | Q44122413 | ||
| Innate immune response to encephalomyocarditis virus infection mediated by CD1d | Q44665307 | ||
| Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells | Q44968943 | ||
| ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. | Q45930388 | ||
| Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis | Q47309667 | ||
| Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production | Q50092377 | ||
| Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation | Q50336029 | ||
| Regulatory T cells are resistant to apoptosis via TCR but not P2X7. | Q53018663 | ||
| C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. | Q53767913 | ||
| Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells | Q57920567 | ||
| Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide | Q63363342 | ||
| IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. | Q64976680 | ||
| Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A | Q71215744 | ||
| Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation | Q73114534 | ||
| Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages | Q73535863 | ||
| Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice | Q73535883 | ||
| Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice | Q83053913 | ||
| Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism | Q83856404 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 841-852 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis | |
| P478 | volume | 48 |
| Q36935733 | 5'-AMP impacts lymphocyte recirculation through activation of A2B receptors |
| Q38849452 | A critical look at the function of the P2Y11 receptor |
| Q58787642 | ATP as a Pathophysiologic Mediator of Bacteria-Host Crosstalk in the Gastrointestinal Tract |
| Q101461127 | Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis |
| Q94213720 | Activation of natural killer T cells contributes to triptolide-induced liver injury in mice |
| Q37623573 | Attenuated allergic airway inflammation in Cd39 null mice |
| Q35906055 | Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease |
| Q37351218 | CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice |
| Q52868007 | CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease. |
| Q34569461 | CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy |
| Q34091467 | CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice |
| Q42924000 | CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury |
| Q35088318 | Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease |
| Q98289226 | Clinical significance of herpes virus entry mediator expression in hepatitis B virus-related hepatocellular carcinoma |
| Q34097900 | Corneal epithelium expresses a variant of P2X(7) receptor in health and disease |
| Q84417342 | Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression |
| Q33622444 | Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide. |
| Q33989339 | Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice |
| Q36842553 | Deletion of cd39/entpd1 results in hepatic insulin resistance |
| Q36420128 | Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice |
| Q50890424 | Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. |
| Q37876541 | Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity |
| Q64075135 | Ectonucleotidases in Intestinal and Hepatic Inflammation |
| Q33744649 | Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. |
| Q38959199 | Expression of mediators of purinergic signaling in human liver cell lines. |
| Q38464138 | Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization |
| Q37775889 | Extracellular adenosine triphosphate and adenosine in cancer. |
| Q37560398 | Extracellular nucleotides as negative modulators of immunity |
| Q57444218 | Induction of antiinflammatory purinergic signaling in activated human iNKT cells |
| Q86077064 | Innate immunity, purinergic system, and liver regeneration: a trip in complexity |
| Q35574518 | Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia |
| Q46151387 | Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells |
| Q37326768 | Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases |
| Q46026307 | Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives. |
| Q34610192 | NTPDase1 governs P2X7-dependent functions in murine macrophages |
| Q34464511 | Nucleotide signalling during inflammation |
| Q36446067 | P2 receptors and immunity. |
| Q60220469 | P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration |
| Q34658181 | P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death |
| Q60556931 | Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis |
| Q36999844 | Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury |
| Q38753350 | Purinergic regulation of the immune system |
| Q38230723 | Purinergic signaling in liver disease. |
| Q38263455 | Purinergic signalling and immune cells |
| Q38165746 | Purinergic signalling in the liver in health and disease |
| Q30435545 | Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration |
| Q26741191 | Role of NK, NKT cells and macrophages in liver transplantation |
| Q35999515 | Role of purinergic P2X receptors in the control of liver homeostasis. |
| Q51621241 | Selection of reference genes for qRT-PCR in high fat diet-induced hepatic steatosis mice model. |
| Q43298814 | Tanshinone IIA protects against immune-mediated liver injury through activation of T-cell subsets and regulation of cytokines. |
| Q34257834 | The A2aR adenosine receptor controls cytokine production in iNKT cells |
| Q39683781 | The P2X4 purinergic receptor impacts liver regeneration after partial hepatectomy in mice through the regulation of biliary homeostasis |
| Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
| Q39161005 | The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets |
| Q30409961 | The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation |
| Q37251564 | Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer |
| Q34633667 | Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate |
Search more.